Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04201457
Title A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Pediatric Brain Tumor Consortium

high grade glioma


Hydroxychloroquine + Trametinib

Dabrafenib + Hydroxychloroquine + Trametinib

Age Groups: child | adult
Covered Countries USA

Additional content available in CKB BOOST